On ECHEMI
Home > Drugs > Hereditary spastic paraplegia
Hereditary spastic paraplegia
Hereditary spastic paraplegia (HSP) was first reported by Seeligmuller (1874). It is a syndrome characterized by progressive hypertonia, weakness and scissor gait in the lower limbs. The clinical manifestations are mainly slow-progressing spastic paraplegia with various symptoms. Most scholars classify it as hereditary ataxia, accounting for about 1/4 of the total incidence of the latter.
  • Site of disease:

    spinal cord
  • Infectious :

    Not contagious
  • Frequent population:

    Most often present in childhood or adolescence
  • Related symptoms:

    Ataxia Visual impairment Hyperflexia Hypertonia Spastic paraplegic gait
  • Concurrent disease:

Related Drugs
Baclofen
Indication: No data yet
Manufacturer:

Fuan Pharmaceutical Group Ningbo Team Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.